CLARK IAN T

CIK 000133650414 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001336504

Recent Transactions

50 trades

Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2026-06-18+29,500→ 29,500 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2026-06-17+5,092→ 8,067 total
Exercise/Conversion
Guardant Health, Inc.$GH
Restricted Stock Units
2026-06-17−5,092→ 0 total
Award
Guardant Health, Inc.$GH
Restricted Stock Units
2026-06-17+2,711→ 2,711 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-06-11+15,000→ 15,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2026-06-02+7,490→ 14,490 total
Award
Kyverna Therapeutics, Inc.$KYTX
Common Stock
2026-05-27+5,093→ 21,727 total
Award
Kyverna Therapeutics, Inc.$KYTX
Stock Option (right to buy)
2026-05-27+20,582→ 20,582 total
Sale
Guardant Health, Inc.$GH
Common Stock
2026-05-20$106.90/sh−6,876→ 2,975 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2025-12-05$38.42/sh+9,105→ 18,956 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2025-12-05$38.01/sh+8,803→ 27,759 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2025-12-05$31.84/sh+10,703→ 38,462 total
Sale
Guardant Health, Inc.$GH
Common Stock
2025-12-05$106.67/sh−8,156→ 30,306 total
Sale
Guardant Health, Inc.$GH
Common Stock
2025-12-05$107.27/sh−17,055→ 13,251 total
Sale
Guardant Health, Inc.$GH
Common Stock
2025-12-05$108.05/sh−3,400→ 9,851 total
Exercise/Conversion
Guardant Health, Inc.$GH
Stock Option (Right to Buy)
2025-12-05−9,105→ 0 total
Exercise/Conversion
Guardant Health, Inc.$GH
Stock Option (Right to Buy)
2025-12-05−8,803→ 0 total
Exercise/Conversion
Guardant Health, Inc.$GH
Stock Option (Right to Buy)
2025-12-05−10,703→ 0 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2025-08-01+7,000→ 7,000 total
Exercise/Conversion
GoodRx Holdings, Inc.$GDRX
Restricted Stock Unit
2025-07-08−17,248→ 34,497 total
Exercise/Conversion
GoodRx Holdings, Inc.$GDRX
Class A Common Stock
2025-07-08$4.74/sh+17,248→ 100,150 total
Award
Guardant Health, Inc.$GH
Stock Option (Right to Buy)
2025-06-18+6,833→ 6,833 total
Award
Guardant Health, Inc.$GH
Restricted Stock Units
2025-06-18+5,092→ 5,092 total
Sale
Guardant Health, Inc.$GH
Common Stock
2025-06-17$48.38/sh−6,672→ 9,851 total
Exercise/Conversion
Guardant Health, Inc.$GH
Restricted Stock Units
2025-06-12−8,088→ 0 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2025-06-12+15,000→ 15,000 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2025-06-12+8,088→ 16,523 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2025-06-11+24,150→ 24,150 total
Award
GoodRx Holdings, Inc.$GDRX
Class A Common Stock
2025-06-03+57,050→ 82,902 total
Award
Kyverna Therapeutics, Inc.$KYTX
Stock Option (right to buy)
2025-05-29+65,351→ 65,351 total
Award
Kyverna Therapeutics, Inc.$KYTX
Common Stock
2025-05-29+16,634→ 16,634 total
Other
Guardant Health, Inc.$GH
Common Stock
2024-11-12−8,435→ 0 total
Other
Guardant Health, Inc.$GH
Common Stock
2024-11-12+8,435→ 8,435 total
Exercise/Conversion
Guardant Health, Inc.$GH
Stock Option (Right to Buy)
2024-11-12−1,076→ 0 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2024-11-12$4.18/sh+1,076→ 16,753 total
Sale
Guardant Health, Inc.$GH
Common Stock
2024-11-12$29.52/sh−1,076→ 15,677 total
Sale
Guardant Health, Inc.$GH
Common Stock
2024-11-12$29.44/sh−7,242→ 8,435 total
Award
GoodRx Holdings, Inc.$GDRX
Class A Common Stock
2024-07-08+25,852→ 25,852 total
Award
GoodRx Holdings, Inc.$GDRX
Restricted Stock Unit
2024-07-08+51,745→ 51,745 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2024-06-14+23,000→ 23,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2024-06-13+15,000→ 15,000 total
Exercise/Conversion
Guardant Health, Inc.$GH
Common Stock
2024-06-12+6,776→ 15,677 total
Exercise/Conversion
Guardant Health, Inc.$GH
Restricted Stock Units
2024-06-12−6,776→ 0 total
Award
Guardant Health, Inc.$GH
Stock Option (Right to Buy)
2024-06-12+10,703→ 10,703 total
Award
Guardant Health, Inc.$GH
Restricted Stock Units
2024-06-12+8,088→ 8,088 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2023-12-06+15,000→ 15,000 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2023-06-16+21,520→ 21,520 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2023-06-15+15,000→ 15,000 total
Exercise/Conversion
Guardant Health, Inc.$GH
COMMON STOCK
2023-06-14+6,703→ 8,901 total
Exercise/Conversion
Guardant Health, Inc.$GH
RESTRICTED STOCK UNITS
2023-06-14−6,703→ 0 total

CLARK IAN T

Recent Transactions

Companies

Recent Filings

Address